Reply to B. O'Sullivan et al

Journal of Clinical Oncology

Volumn 33, Issue 15, 2015, Pages 1708-1709

  Fakhry, Carole ^a   Zhang, Qiang ^b   Nguyen Tan, Phuc Felix ^c   Rosenthal, David ^d   El Naggar, Adel K ^d   Garden, Adam S ^d   Soulieres, Denis ^c   Trotti, Andy ^e   Avizonis, Vilija N ^f   Ridge, John A ^g   Harris, Jonathan ^b   Le, Quynh Thu ^h   Gillison, Maura ⁱ  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f INTERMOUNTAIN MEDICAL CENTER   (United States)

^g FOX CHASE CANCER CENTER   (United States)

^h STANFORD UNIVERSITY MEDICAL CENTER   (United States)

ⁱ THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; PROTEIN P16; TUMOR PROTEIN;

ANATOMIC LANDMARK; CANCER PROGNOSIS; CHEMORADIOTHERAPY; DISEASE COURSE; DISTANT METASTASIS; FOLLOW UP; HUMAN; LETTER; OROPHARYNX CANCER; PRIORITY JOURNAL; FEMALE; ISOLATION AND PURIFICATION; MALE; OROPHARYNX TUMOR; PAPILLOMAVIRIDAE; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; NEOPLASM PROTEINS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE;

EID: 84933515421     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.60.3555     Document Type: Letter

References (10)

1. O'Sullivan B, Adelstein DL, Huang SH, et al: First site of failure analysis incompletely addresses issues of late and unexpected metastases in p16- positive oropharyngeal cancer. J Clin Oncol 33:1707-1708, 2015
2. Michiels S, Le Maitre A, Buyse M, et al: Surrogate endpoints for overall survival in locally advanced head and neck cancer: Meta-analyses of individual patient data. Lancet Oncology 10:341-350, 2009
3. Fakhry C, Zhang Q, Nguyen-Tan PF, et al: Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol 32:3365-3373, 2014
4. Huang SH, Perez-Ordonez B, Liu FF, et al: Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 82:276-283, 2012
5. Sinha P, Thorstad WT, Nussenbaum B, et al: Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: A critical analysis of patterns and outcomes. Oral Oncol 50:45-51, 2014
6. Ruzevick J, Olivi A, Westra WH: Metastatic squamous cell carcinoma to the brain: An unrecognized pattern of distant spread in patients with HPV-related head and neck cancer. J Neurooncol 112:449-454, 2013
7. Pfister DG, Spencer S, Brizel DM, et al: Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 12:1454-1487, 2014
8. O'Sullivan B, Huang SH, Siu LL, et al: Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 31:543-550, 2013
9. McBride SM, Busse PM, Clark JR, et al: Long-term survival after distant metastasis in patients with oropharyngeal cancer. Oral Oncol 50:208-212, 2014
10. Huang SH, Perez-Ordonez B, Weinreb I, et al: Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol 49:79-85, 2013